Symbiosis Pharmaceutical Services (Symbiosis), an international contract manufacturing organisation (CMO) with headquarters in the UK, who specialise in providing GMP aseptic fill and finish services for biologic and small molecule pharmaceuticals to biotechnology and pharmaceutical companies worldwide, has announced a 1 million GBP (1.2 million Euros, 1.3 million USD) investment in its in-house analytical services […]

The post Symbiosis announces £1 million investment in analytical testing capability first appeared on World Pharma Today.